Chemotherapy Response Assay Test and Prognosis for Breast Cancer Patients Who Have Undergone Anthracycline- and Taxane-Based Chemotherapy
Author:
Affiliation:
1. Department of Medicine, Kyung Hee University Graduate School, Seoul, Korea.
2. Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea.
3. Department of Surgery, Kyung Hee University School of Medicine, Seoul, Korea.
Publisher
Korean Breast Cancer Society
Subject
Cancer Research,Oncology
Link
https://synapse.koreamed.org/pdf/10.4048/jbc.2011.14.4.283
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast Cancer;Clinical Breast Cancer;2024-07
2. CD4+ Tumor-infiltrating Lymphocytes in Neoadjuvant Chemotherapy-treated Invasive Breast Cancer of No Special Type;Journal of Nature and Science of Medicine;2024-07
3. Gynecologic and Breast Cancers: What's New in Chemoresistance and Chemosensitivity Tests?;Current Problems in Cancer;2023-08
4. Exploring the Expression of Survivin on Neoadjuvant Chemotherapy in Invasive Breast Carcinoma;Open Access Macedonian Journal of Medical Sciences;2022-06-05
5. The relationship between NFKB, HER2, ER expression and anthracycline -based neoadjuvan chemotherapy response in local advanced stadium breast cancer: A cohort study in Eastern Indonesia;Annals of Medicine and Surgery;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3